Drug Delivery Via The Microbiome

Tenza reprograms symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit. We do so using a ML-powered, synthetic biology platform that enables us to engineer a wider diversity of bacteria to produce higher yields of drugs than ever before.

Founding Team

Scientific Advisory Board

Rob Britton, Ph.D.

Wendy Garrett, M.D., Ph.D.

John March, Ph.D.

Todd Zion, Ph.D.




700 Main St., Cambridge, MA, USA

Anik Debnath, Ph.D.

George Church, Ph.D.

© Tenza, Inc. 2019